About 1 result found for searched term "Y08197" (0.119 seconds)
Cat.No. | Name | Target |
---|---|---|
M45246 | Y08197 | Epigenetic Reader Domain |
Y08197 is a novel selective CBP/EP300 bromodomain inhibitor for prostate cancer-related studies. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.